TGA

The Iran war may disrupt access to medicines

While PBS stock‑holding rules provide a buffer against short disruptions, experts warn that prolonged conflict in the Middle East could…

Year in review: Dementia breakthroughs

Dementia has surpassed heart disease to become the leading cause of death in Australia, a statistic confirmed by the Australian…

No PBS for new Alzheimer’s therapy

The Pharmaceutical Benefits Advisory Committee has rejected an application for a newly approved Alzheimer’s treatment to be included on the…

Dementia drug rejected by TGA

The Therapeutic Goods Administration (TGA) has decided not to register Alzheimer's drug lecanemab (LEQEMBI) on the basis that "the demonstrated…

FDA approves drug for early symptomatic Alzheimer’s disease

The U.S. Food and Drug Administration (FDA) has approved the Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease after months of…